Skip to content

Machine Learning Model Based on Baroreflex Sensitivity for Predicting Post-Induction Hypotension in Elderly Patients

Development of a Baroreflex Sensitivity-Based Multifactorial Machine Learning Model for Predicting Post-Induction Hypotension in Elderly Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07618416
Enrollment
500
Registered
2026-06-01
Start date
2026-06-01
Completion date
2027-12-31
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Induction Hypotension

Keywords

post-induction hypotension, elderly patient, baroreflex sensitivity, machine learning

Brief summary

The purpose of this study is to develop a high-performance machine learning model combining dynamic baroreflex sensitivity (BRS) metrics and multi-dimensional static clinical features to predict the risk of post-induction hypotension (PIH) in elderly patients undergoing elective non-cardiac surgery under general anesthesia.

Detailed description

Aging significantly alters cardiovascular autonomic function, characterized by elevated sympathetic and decreased parasympathetic tone, rendering elderly patients highly vulnerable to post-induction hypotension (PIH). While existing machine learning models heavily rely on static data (e.g., baseline blood pressure, demographics, medication history), they lack real-time dynamic regulatory inputs, limiting their predictive performance in individualized care. This single-center, prospective cohort study aims to bridge this gap by introducing preoperative BRS parameters-calculated via the continuous non-invasive arterial pressure (CNAP) method-into machine learning frameworks. A total of 500 patients aged over 65 years scheduled for elective non-cardiac surgery will be enrolled. Preoperative data, including autonomic indices, frailty assessments, and static clinical factors, will be mapped alongside intraoperative events and 30-day postoperative complications. Multiple machine learning algorithms (Logistic Regression, Random Forest, GBDT, XGBoost, LightGBM, and LSTM) will be leveraged and optimized using cross-validation to construct a robust clinical decision-support pipeline.

Interventions

None listed

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Aged over 65 years; * Scheduled for elective non-cardiac surgery; * American Society of Anesthesiologists (ASA) physical status classification I-III; * Planned for general anesthesia with endotracheal intubation; * Patient and legal guardians are capable of understanding the study protocol and willing to provide written informed consent.

Exclusion criteria

* Severe peripheral vascular diseases; * Secondary hypertension; * Presence of physical tremors (e.g., Parkinson's disease) preventing stable recording; * Inability to accurately measure upper limb blood pressure; * Pre-existing cardiac arrhythmias (e.g., atrial fibrillation) that render BRS; * Psychiatric disorders or cognitive impairments hindering basic cooperation.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Post-Induction Hypotension (PIH)From immediately after anesthesia induction up to 20 minutes post-induction or before surgical incision.Defined as a systolic blood pressure (SBP) \<90 mmHg , a mean arterial pressure (MAP) \<65 mmHg, or a decrease in MAP exceeding 30% from baseline measurements.

Secondary

MeasureTime frameDescription
1. Early Intraoperative Hypotension RateFrom surgical incision to the end of the operation.Defined as a systolic blood pressure (SBP) \<90 mmHg , a mean arterial pressure (MAP) \<65 mmHg, or a decrease in MAP exceeding 30% from baseline measurements.
Postoperative ComplicationUp to 30 days post-surgery

Countries

China

Contacts

CONTACTQuexuan Cui, Dr.
Cuiqx_garfield@126.com+8613520921711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026